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Introduction
Aldose reductase (AR2V), a putative "hypertonicity stress protein" whose gene is induced by hyperosmolarity, protects renal medullary cells against the interstitial hyperosmolarity of antidiuresis by catalyzing the synthesis of millimolar concentrations of intracellular sorbitol from glucose. Although AR2 gene induction has been noted in a variety of renal and nonrenal cells subjected to hypertonic stress in vitro, the functional significance of AR2 gene expression in cells not normally exposed to a hyperosmolar milieu is not fully understood. The physiological impact of basal AR2 expression in such cells may be limited to hyperglycemic states in which AR2 promotes pathological polyol accumulation, a mechanism invoked in the pathogenesis of diabetic complications. Since AR2 overexpression in the retinal pigment epithelium has been associated with diabetic retinopathy, the regulation of AR2 gene expression and associated changes in sorbitol and myo-inositol were studied in human retinal pigment epithelial cells in culture. The relative abundance of aldehyde reductase (AR1) and AR2 mRNA was quantitated by filter hybridization of RNA from several human retinal pigment epithelial cell lines exposed to hyperglycemic and hyperosmolar conditions in vitro. AR2 but not AR1 mRNA was significantly increased some 11-to 18 -fold by hyperosmolarity in several retinal pigment epithelial cell lines. A single cell line with a 15-fold higher basal level of AR2 mRNA than other cell lines tested demonstrated no significant increase in AR2 mRNA in response to hypertonic stress. This cell line demonstrated accelerated and exaggerated production of sorbitol and depletion of myo-inositol upon exposure to 20 mM glucose. Therefore, abnormal AR2 expression may enhance the sensitivity of cells to the biochemical consequences of hyperglycemia potentiating the development of diabetic complications. (J. Clin. Invest. 1993. 92:617-623.) Key words: diabetic retinopathy * aldehyde reductase * myo-inositol * sorbitol * osmolyte Hyperglycemia has been strongly implicated in the development of the chronic complications of diabetes, but the specific pathogenetic pathways and their possible modulation by genetic and environmental factors remain the subject of speculation and controversy ( 1) . Metabolism of excess tissue glucose to sorbitol by the enzymes aldehyde and aldose reductase (ARl' [EC 1.1.1.2 ] and AR2 [EC 1.1.1.21], respectively) has recently received widespread consideration as a potentially important tissue-specific mechanism of glucose toxicity (2, 3) . Some of the potential adverse effects of increased glucose flux through the sorbitol pathway have been ascribed to secondary alterations in intracellular myo-inositol (MI) metabolism (4) perhaps due to depletion of specific intracellular MI pools (5, 6) . The mechanisms leading to depletion of intracellular MI is poorly understood, but may be due to the action ofsorbitol and MI as alternative non-ionic intracellular osmolytes (7). Accumulation ofintracellular sorbitol may be accompanied by reciprocal decreases in other intracellular osmolytes, such as MI, betaine, or glycerophosphorylcholine in order to maintain osmotic equilibrium. Other mechanisms by which increased flux through the sorbitol pathway might cause tissue damage include perturbation in the NADP+/NADPH and NAD+/ NADH redox couples linked to the AR and sorbitol dehydrogenase oxidoreductase enzymes, respectively (8, 9) , and/or direct osmotic effects of accumulated intracellular sorbitol ( 10) .
Osmotic stress has recently emerged as a major regulator of the genes for AR2 and the Na+-MI cotransporter in the renal medulla, where sorbitol and MI function physiologically as intracellular osmolytes that compensate for the high interstitial osmolarity required for antidiuresis (7, 1 1 ). Under these circumstances, elevated extracellular osmolarity is thought to increase AR2 and MI-transporter gene expression, protein synthesis, and activity (1 1, 12) . Increased AR2 gene expression, immunoreactivity and enzymatic activity in a variety oftissues and cells have also been associated with diabetes and its chronic complications in man and animals (13) (14) (15) . AR2 immunoreactivity is increased in the retinal pigment epithelial (RPE) cell layer in eyes obtained at autopsy from diabetic subjects with and without proliferative diabetic retinopathy, with a greater increase in the former ( 13) . The RPE cell layer exhibits sorbitol accumulation, MI depletion, and impaired Na+/ K+-ATPase activity in diabetic rabbits (16, 17) . Moreover, electroretinographic impairment in diabetic pigmented rats is ascribed to dysfunction of the RPE cell layer and is corrected by either aldose reductase inhibitors (ARI) or by MI supple-mentation (18 ) . Therefore, cultured RPE cells from a variety of mammalian species including humans have been examined as an in vitro model of biochemical and functional defects that may contribute to the pathogenesis of some diabetic complications in vivo (19, 20) . Human RPE cells in culture demonstrate glucose-induced, ARI-sensitive MI depletion, which is associated with a reversible reduction in the rate of uptake of 1251-labeled human retinal rod outer segments, an important function of the RPE cell (20) . The (20) . In brief, RPE cells were recovered with fire-polished Pasteur pipettes under direct observation with a dissecting microscope from surgically removed, sagittally bisected eyes, obtained from the Michigan Eye Bank within 24 hr post-mortem, and cultured in Ham's F1 2 nutrient medium containing 16% FBS, 2 mM glutamine, 100 U/ml penicillin, 100 ,g/ml streptomycin, and 26 mM sodium bicarbonate in a 370C, humidified 5% CO2 atmosphere. Colony-forming primary cultures were rinsed with Hanks' balanced salt solution and passaged with 0.5 mg/ml trypsin and 0.53 mM EDTA in normal saline at 370C for 10 min, centrifuged for 5 min at 50 g, resuspended in new culture medium and replated (21) . The established RPE cell lines were passaged at a density of 40- = 90-120 AM) and 5 mM glucose (20) . All experiments were performed between passages 19 and 24 of 4 RPE cell lines described in Table I . Passaged cells were plated to yield near-confluent cultures at the end of 1-and 7-d experiments (20) . Six-well plates (9.62 cm2) or 175 cm2 dishes were used for metabolic studies or RNA isolation, respectively. The freshly plated cells were allowed to attach in standard growth medium for 24 h and then incubated for various times in MEM containing 5% calf serum and various supplements (see below). RPE (20) where flux through the polyol pathway would be stimulated primarily by mass action (8) . 300 mM glucose was considered a combined osmotic stimulus in the presence of maximal substrate concentrations for the AR reactions. Cultures were routinely examined by phase contrast microscopy and survival estimated by trypan blue exclusion. Neither cell morphology nor survival was detectable altered by the experimental conditions employed in these studies.
Preparation of ARI and AR2 cDNA from RPE mRNA by PCR amplification. Total RNA was purified from cultured human RPE cells by a modification of the method of Stallcup and Washington (22) . Oligo-dT primed cDNA was prepared from 20 Mg of total RPE cell RNA and reverse transcribed with Superscript(Bethesda Research Laboratories, Gaithersburg, MD) according to the vendor's protocol. ARl and AR2 cDNAs were selectively PCR amplified using Amplitaq (Perkin-Elmer Corp., Norwalk, CT), the vendor's buffer and synthetic oligonucleotide primers for human hepatic ARl (5TATAAGCTT-GCTACGACTCCACCCACTA3' and 5'ATATCTAGATGHCTT-CATCTCTTCTGGGCT3') and placental AR2 (5TATAAGCTT-AGAAGCTCAGGGAGCAGGT3' and 5'ATATCTAGAGGTCAC-CACGATGCCTTTG3') cDNA (23), anchored with either HindIII or XbaI sites. Oligonucleotides were synthesized by the DNA Synthesis Core Facility, a part of the University of Michigan's Biomedical Research Core Facilities, on automated DNA synthesizers (Applied Biosystems, Inc., Foster City, CA) employing fl-cyanoethyl phophoramidite chemistry on controlled pore glass support. After 30 cycles (950C, 1.5 min denaturation; 540C, 1.5 min annealing; and 720C, 1.5 min extension) a single major amplification product was identified for each primer pair. The subcloned amplification products obtained with ARI or AR2 primers each exhibited 100% sequence identity with human hepatic ARl and placental AR2 cDNAs (23), respectively, but had only 35% nucleotide identity with each other. The purified cDNA inserts for RPE ARl and AR2 were labeled with random primers and [32P]dCTP (3000 Ci/mM; Amersham) to a specific activity of 109 dpm/Ag (24) .
Filter hybridization of RNA from RPE cells. 10 Mg of denatured total RNA was resolved on 2.2 M formaldehyde 1% agarose gels, transferred by capillary blotting to Zetabind filters (Cuno, Inc., Meriden, CT) stained with methylene blue and photographed. Because of the large differences in the abundance of AR2 mRNA in many of the samples, quantitation was performed with serial dilutions (64-to 128-fold) of RNA applied with a vacuum manifold to Zetabind filters. The filters were fixed in vacuo at 80'C for 2 h, and prehybridized at 650C in 0.5 M NaH2PO4 pH 7.0, 1 mM EDTA, 7% SDS, and 1% BSA for 4-6 h before adding the denatured AR2 cDNA probe (106 dpm/ml) (25). After 18 h, filters were washed twice with 40 mM NaH2PO4 pH 7.0, 1 mM EDTA, 7% SDS at 650C, and 4 times with 40 mM NaH2PO4 pH (Figs. 4 and 5) . In agreement with previous data, 20 mM glucose has no effect on AR2 mRNA levels in any cell line (P > 0.05). The mRNA encoding ARl, another oxido-reductase capable of metabolizing glucose to sorbitol, was not significantly changed by this treatment, and no significant change in vimentin or fl-actin mRNA was noted (Fig. 4) . In contrast, the basal level of AR2 mRNA in RPE 91 cells (isotonic medium, 5 mM glucose) was 14-to 17-fold higher than the basal AR2 mRNA level in RPE 125, 0308, or 45 cells (P < 0.001 ), and there was no significant increase in AR2 mRNA after exposure to 300 mM glucose for 24 h or 7 d (Figs. 4-6 ). from three independent experiments were quantitated using a laser densitometer. The radiodensity obtained was corrected for differences in ,B-actin abundance before statistical analysis. There was no difference in AR2 mRNA abundance between 5 and 20 mM glucose in any cell.type. An effect of glucose on AR2 mRNA was evident only in RPE cell lines 125, 0308, and 45 (P < 0.02). The level of AR2 mRNA in RPE 91 cells exposed to 5 or 20 mM glucose was significantly higher than any, other cell line (*P < 0.001). The basal level of AR2 mRNA in RPE 91 cells was 14-to 17-fold higher than that in any other cell type.
trast, modest sorbitol accumulation (42.8 nm/mg protein) was detectable in RPE 91 cells within 24 h of exposure to 20 mM glucose, and marked sorbitol accumulation and MI depletion were evident (sorbitol, 428.7 nm/mg protein, P < 0.001; MI, 29.6 nm/mg protein to 11.4 nm/mg protein, P < 0.001) in 300 mM glucose. After 7 d, sorbitol accumulation (468.6 nm/mg protein, P < 0.001) and MI depletion (44.0 nm/mg protein to 1.7 nm/mg protein, P < 0.001) was clearly exaggerated in RPE 91 cells compared with RPE 45 cells at 20 mM and 300 mM glucose. Discussion RPE cell lines from three human donors (RPE cell lines 125, 0308, and 45) exhibited low basal levels of AR2 mRNA when cultured in isotonic medium and an 11-to 18-fold increase in AR2 mRNA in response to 300 mM glucose. These results are similar to those reported in a variety of renal and nonrenal cells, including rat glomerular mesangial cells, dog kidney endothelial cells, dog and rat lens epithelial cells, and Chinese hamster ovary cells, (7, 12, (29) (30) (31) (32) (33) (34) (35) 7 day exposure Figure 6 . Effect of chronic exposure to glucose. RPE cell lines 45 and 91 were exposed to 20 mM or 300 mM glucose for 7 (36) . The decline in AR2 mRNA in RPE 45 cells may be due to the "feedback" effect of metabolites ofthe enzymatic reaction catalyzed by AR2 (e.g., sorbitol accumulation), as has been proposed for renal medulla (37). Despite the presence of markedly elevated sorbitol levels in RPE 91 cells (nearly threefold greater than RPE 45), AR2 mRNA levels were unchanged after 7 d exposure to 300 mM glucose. These data would suggest that AR2 gene expression in RPE 91 cells is unresponsive to both hyperosmotic stimuli and to putative feedback inhibition by polyol pathway intermediates, consistent with the hypothesis that the AR2 gene is essentially unregulated in RPE 91 cells.
The regulation ofthe AR2 gene expression has been studied best in the renal medulla, where sorbitol is one of several alternative non-ionic organic intracellular osmolytes produced in response to the physiological extracellular hyperosmolarity associated with antidiuresis (7). This "nonperturbing" class of intracellular organic osmolytes, which includes sorbitol, MI, betaine, and glycerophosphorylcholine (7, 11, 32, 33) , maintains intracellular osmolarity without disrupting the intracellular ionic environment (7). Extracellular hyperosmolarity has been shown to increase AR2 gene transcription and AR2 mRNA stability, leading to an increased steady-state level of AR2 mRNA (38) and subsequently AR2 protein (34 (32) . Since substrate-induced, iso-osmotic sorbitol accumulation would be unaccompanied by osmotic induction of MI accumulation, MI levels could reach levels sufficiently low as to limit phosphatidylinositol synthesis (20) . This degree of MI depletion has been produced in RPE 91 cells with high constitutive AR2 gene expression by brief exposure to 20 mM glucose, and such alterations in phosphoinositide metabolism have been invoked in the pathogenesis of some diabetic complications (41 ) .
Pathways ofglucose metabolism whose flux varies with prevailing hyperglycemia are often invoked as potential mediators of the chronic diabetic complications whose cumulative duration and severity parallel that of hyperglycemia (2, 42 ). Yet these metabolic pathways, such as nonenzymatic glycation and the polyol pathway, are rarely invoked to explain the wide variation ofdiabetic complications among patients with hyperglycemia ofsimilar degree and duration ( 1 ). Fragmentary but nevertheless provocative data now link the tissue-specific catalytic capacity or protein content of aldose reductase-like enzymes with the prevalence and/or severity of diabetic complications (13, 15) . The availability of cDNA sequences for RPE ARl and AR2, and the delineation of the structure of the human AR2 gene (43) provide highly specific tools to independently study normal and abnormal regulation of these genes. (44) should provide an important new system in which to explore these possibilities and potentially to identify genetic markers that might sensitize subgroups of diabetic patients to the effects of hyperglycemia.
